chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 11.0
Sex: M
Vaccine: MNQ, TDAP
Symptoms: Erythema, Inflammation, Local swelling, Skin warm
Clinical narrative: Case number PHHY2012US076892, is an initial spontaneous report received from Vaccine Adverse Event Reporting System (VAERS reference number: 457461) on 05 Sep 2012. This report refers to an 11 year old male patient. Medical history was not reported. He was vaccinated with MENVEO (batch number: A10132), in left arm, on 12 Jun 2012 and vaccinated with BOOSTRIX (batch number: AC52B080AA) in right arm. On 13 Jun 2012, his left arm began to turn red and inflamed. 48 hours, even after BENADRYL and cool compress, the area was larger and hot to touch, red and swollen. Event outcome was recovered. Seriousness and causality of the events were not reported.
Age: 11.0
Sex: M
Vaccine: MNQ
Symptoms: Injection site erythema, Vaccination site abscess, Vaccination site swelling
Clinical narrative: Case number PHHY2012US076894, is an initial spontaneous report received from Vaccine Adverse Event Reporting System (VAERS reference number: 457626) on 05 Sep 2012. This report refers to an 11-year-old male patient. Medical history was not reported. He was vaccinated with MENVEO (batch number: M11032), in left arm, on 15 Jun 2012. On 16 Jun 2012, the child reported that the vaccination area was itchy, red and swollen. The child's mother gave BENADRYL and applied ice to the area. The symptoms lasted for two days. The outcome of the events were completely recovered. Seriousness and causality of the events were not reported.
Age: 16.0
Sex: F
Vaccine: MNQ
Symptoms: Injection site erythema, Injection site pain, Injection site warmth, Malaise, Pain
Clinical narrative: Case number PHHY2012US076897, is an initial spontaneous report received from Vaccine Adverse Event Reporting System (VAERS reference number: 457688) on 05 Sep 2012. This report refers to 16 year old female patient. Medical history was not reported. She was vaccinated with MENVEO (batch number: M10123), in left arm, on 18 Jun 2012. On the same day the patient experienced general malaise, erythema in left upper arm of 13/9 mm and the area was warm to touch, sore to move swollen arm. The event outcome was recovered. Seriousness and causality of the events were not reported.
Age: 11.0
Sex: M
Vaccine: MNQ, TDAP, VARCEL
Symptoms: Injection site pruritus, Injection site urticaria
Clinical narrative: Case number PHHY2012US076900, is an initial spontaneous report received from Vaccine Adverse Event Reporting System (VAERS reference number: 457858) on 05 Sep 2012. This report refers to an 11 year old male patient. Medical history was not reported. He was vaccinated with MENVEO (batch number: M10130), intramuscularly, in right arm, on 13 Jun 2012. He was also vaccinated with BOOSTRIX (batch number: AC52B070BA) intramuscularly, in left arm, on 13 Jun 2012 and VARIVAX (batch number: 0080AE) subcutaneously, in right arm, 13 Jun 2012. Concomitant medications included PROZAC and INTUNIV. Less than five minutes after vaccination the patient began to itch, localized hive at the vaccination site. No respiratory symptoms observed for fifteen more minutes. Antihistamines (unspecified) were given by mouth.
Age: 11.0
Sex: F
Vaccine: HEPA, MNQ, TDAP
Symptoms: Abdominal pain upper, Back pain, Body temperature increased, Chills, Nausea
Clinical narrative: Case number PHHY2012US076905 is an initial spontaneous report received from Vaccine Adverse Event Reporting System (VAERS reference number: 457962) web site on 05 Sep 2012. This report refers to an 11-year-old female patient whose medical history, past drugs, current conditions and concomitant medications were not provided. She was vaccinated with MENVEO (batch number: M10133) intramuscularly on to right arm and BOOSTRIX (batch number: AC52B074CA) and HAVRIX (batch number: AHAVB550BA) intramuscularly on to left arm on 20 Jun 2012. On 21 Jun 2012 she woke up early morning complaining of right arm pain, back pain, stomach pain, nausea and chills. Her temperature was 100.5 F. She did not have swelling, redness or rash at vaccination site initially. She was advised to see a physician and she went to doctor in the afternoon with redness and swelling at right arm shoulder. Laboratory test (unspecified) indicated urinary tract infection. She was treated with antibiotics, PHENERGAN. The final outcome of the events was reported as complete recovery as of 22 Jun 2012.
Age: 11.0
Sex: F
Vaccine: HEPA, MNQ, TDAP
Symptoms: Pain in extremity, Urinary tract infection
Clinical narrative: Case number PHHY2012US076905 is an initial spontaneous report received from Vaccine Adverse Event Reporting System (VAERS reference number: 457962) web site on 05 Sep 2012. This report refers to an 11-year-old female patient whose medical history, past drugs, current conditions and concomitant medications were not provided. She was vaccinated with MENVEO (batch number: M10133) intramuscularly on to right arm and BOOSTRIX (batch number: AC52B074CA) and HAVRIX (batch number: AHAVB550BA) intramuscularly on to left arm on 20 Jun 2012. On 21 Jun 2012 she woke up early morning complaining of right arm pain, back pain, stomach pain, nausea and chills. Her temperature was 100.5 F. She did not have swelling, redness or rash at vaccination site initially. She was advised to see a physician and she went to doctor in the afternoon with redness and swelling at right arm shoulder. Laboratory test (unspecified) indicated urinary tract infection. She was treated with antibiotics, PHENERGAN. The final outcome of the events was reported as complete recovery as of 22 Jun 2012.
Age: 11.0
Sex: M
Vaccine: HPV4, MNQ
Symptoms: Blister, Erythema, Swelling
Clinical narrative: Case number PHHY2012US076907 is an initial spontaneous report received from vaccine adverse event reporting system (VAERS reference number: 458031) web site on 05 Sep 2012. This report refers to an 11-year-old male patient. His medical history, past drugs, current conditions and concomitant medications were not reported. He was vaccinated with MENVEO (batch number: M10134A) and GARDASIL (batch number: 1495AA), both vaccines through unspecified route on to right arm on 22 Jun 2012. On 23 Jun 2012, he experienced swelling and redness with large blisters. The outcome of the events was reported as condition unchanged as of 25 Jun 2012.
Age: 18.0
Sex: F
Vaccine: MNQ
Symptoms: Dizziness, Heart rate decreased
Clinical narrative: Case number PHHY2012US076910 is an initial spontaneous report received from Vaccine Adverse Event Reporting System (VAERS reference number: 458096) website on 05 Sep 2012. This report refers to an 18-year-old female patient. Her medical history included surgery for congenitally blocked ureter of left kidney and her past drugs, current conditions and concomitant medications were not reported. Her vaccination history included administration of unspecified vaccines in 2005 or 2006 and syncope episode following it. She was vaccinated with MENVEO (batch number: M10057) intramuscularly on to left arm on 22 Jun 2012. On the same day, she became lightheaded while getting ready to leave the health department with her mother. She was laid down with cool cloth on forehead and was offered water and crackers. Her vital signs were checked and her blood pressure was 112/66 (units not reported), pulse rate was 48 (units not reported) initially. It was reported that later she felt better with blood pressure 99/63 (units not reported) and pulse rate 59 (units not reported). The outcome of the events was reported as complete recovery as of 25 Jun 2012.
Age: 17.0
Sex: F
Vaccine: MNQ
Symptoms: Dissociation, Dizziness, Headache
Clinical narrative: Case number PHHY2012US076914, is an initial spontaneous report received from Vaccine Adverse Event Reporting System (VAERS reference number: 458180) on 05 Sep 2012 with an internal review received on 27 Sep 2012. This report refers to a 17 year old female patient. Medical history was not reported. She was vaccinated with MENVEO (batch number: A11071), intramuscularly, in left arm, on 13 Jun 2012. Post vaccination the patient experienced headache, light headed and disconnected feeling. Treatment medications included ibuprofen 3 tablets, oral TID and PHENERGAN 50 mg, oral every 6 hours. The outcome of the events was recovered. Seriousness and causality of the events were not reported. Following an internal review on 26 Sep 2012, the case PHHY2012US076915 was found to be a duplicate of PHHY2012US076914 and hence all the information from PHHY2012US076915 was merged with PHHY2012US076914 and the case PHHY2012US076915 was deactivated.
Age: 12.0
Sex: M
Vaccine: MNQ
Symptoms: Injection site erythema, Injection site swelling, Injection site warmth
Clinical narrative: Case number PHHY2012US076942 is an initial spontaneous report received from Vaccine Adverse Event Reporting System (VAERS: 458242) web site on 05 Sep 2012. This report refers to 12-year-old male patient. The patient was vaccinated with MENVEO (batch number: A11071) in left arm on 20 Jun 2012. On 21 Jun 2012, after the vaccination, the patient's injection site was swollen, red and hot in the area of 10 cm (+) on left deltoid. The outcome of events was reported as recovery as of 27 Jun 2012.
Age: 12.0
Sex: F
Vaccine: MEN, MNQ
Symptoms: Dizziness, Headache, Nausea, Vomiting
Clinical narrative: Case number PHHY2012US076944 is an initial spontaneous report received from Vaccine Adverse Event Reporting System (VAERS: 458225) web site on 05 Sep 2012. This report refers to 12-year-old female patient. The patient was vaccinated with MENVEO (batch number: M10129) in left arm and MCV4 (batch number: not reported, other manufacture) on 21 Dec 2011. On 24 Dec 2011, the patient experienced bad headache, dizziness, vomiting and nausea. The patient had regular urination and good appetite. The outcome of events was reported as recovery as of 27 Jun 2012.
Age: 13.0
Sex: M
Vaccine: MNQ
Symptoms: Erythema, Skin warm, Swelling
Clinical narrative: Case number PHHY2012US076824 is an initial spontaneous report received from vaccine adverse event reporting system (VAERS reference number: 458274) on 05 Sep 2012. This report refers to 13-years-old male patient. His medical history, past drugs and current conditions were not reported. He was vaccinated with MENVEO (batch number: A11071) intramuscularly on to arm on 26 Jun 2012. He experienced his skin red, swollen and hot to touch on 27 Jun 2012. The outcome of the events was reported as complete recovery as on 27 Jun 2012.
Age: 29.0
Sex: F
Vaccine: MNQ
Symptoms: Pain, Peripheral swelling
Clinical narrative: Case number PHHY2012US076827 is an initial spontaneous report received from vaccine adverse event reporting system (VAERS reference number: 458362) web site on 05 Sep 2012. This report refers to 29-year-old female patient. Her medical history included fibromyalgia. She was vaccinated with MENVEO (batch number: M10126) intramuscularly on to right arm on 14 Feb 2012. On the same day, she experienced her arm became very swollen and throbbing with pain a short time after vaccination. Following these events she made a visit to the emergency room. She was advised to apply an ice pack. The final outcome of the events was reported as recovered on 28 Jun 2012. No additional information about the causality of the events was available.
Age: 10.0
Sex: M
Vaccine: MNQ, TDAP
Symptoms: Injection site erythema, Vaccination site swelling, Vaccination site warmth
Clinical narrative: Case number PHHY2012US076828 is an initial spontaneous report received from Vaccine Adverse Event Reporting System (VAERS reference number: 458371) web site on 05 Sep 2012. This report refers to 10-year-old male patient. His medical history, past drugs and current conditions were not reported. He was vaccinated with MENVEO (batch number: A11042) along with BOOSTRIX (batch number: AC52B079BA and other manufacturer) intramuscularly on to left arm on 26 Jun 2012. After vaccination, he experienced redness, swelling and warmth to deltoid muscle at vaccination site on 27 Jun 2012. The final outcome of the events was condition unchanged. No additional information about the causality of the events was available.
Age: 12.0
Sex: M
Vaccine: HPV4, MNQ, TDAP, VARCEL
Symptoms: Injection site discolouration, Injection site erythema
Clinical narrative: Case number PHHY2012US076830 is an initial spontaneous report received from Vaccine Adverse Event Reporting System (VAERS reference number: 458379) web site on 05 Sep 2012. This report refers to 12-year-old male patient. His medical history, past drugs and current conditions were not reported. He was vaccinated with MENVEO (batch number: A10126) intramuscularly in the left arm, BOOSTRIX (other manufacture, batch number: 0975AA) intramuscularly on to left arm, GARDASIL (other manufacture, batch number: A10126) intramuscularly on to right arm and VARIVAX (other manufacture, batch number: AC52B072EA) intramuscularly on to right arm on 14 Mar 2012. On 15 Mar 2012, he experienced some blue and red discoloration of deltoid area of both arms. The final outcome of the events was reported as recovered. The causality of the events was not reported.
Age: 19.0
Sex: F
Vaccine: MNQ, TDAP
Symptoms: Dizziness, Photophobia, Pyrexia, Swelling
Clinical narrative: Case number PHHY2012US076832 is an initial spontaneous report received from Vaccine Adverse Event Reporting System (VAERS reference number: 458393) web site on 05 Sep 2012. This report refers to 19-year-old female patient. Her medical history, past drugs and current conditions were not reported. She was vaccinated with MENVEO (batch number: M11075) intramuscularly in the right arm and TD absorbed (other manufacture, batch number: C4114AA, diphtheria and tetanus toxoids) intramuscularly in the right arm on 20 Jun 2012. On the same day after vaccination, she experienced swelling all over body with low grade temperature of 99 degrees. She also experienced dizziness, sensitivity to light. She underwent blood test and showed negative (normal). She was treated with steroids (unspecified) for four-days. The final outcome of the events was reported as condition unchanged at the time of reporting (28 Jun 2012). The causality of the events was not reported.
Age: 27.0
Sex: F
Vaccine: FLU3, HEP, HEPA, MNQ, TDAP
Symptoms: Cold sweat, Dizziness, Hyperhidrosis, Immediate post-injection reaction, Pallor
Clinical narrative: Case number PHHY20120US076834 is an initial spontaneous report received from Vaccine Adverse Event Reporting System (VAERS reference number: 458428) website on 06 SEP 2012. This report refers to 27-year old female patient. Her medical history, past drugs, and current conditions were not reported. She was vaccinated with MENVEO (batch number: M10126A) in the left arm, Engerix-B (other manufacturer, batch number AHBVB991AB) in the left arm; FLUZONE (other manufacturer, batch number: UH47AC) in the right arm, HAVRIX (other manufacturer , batch number AHAVB38AA) in the right arm and BOOSTRIX (other manufacturer, batch number: U4088CA) in the right arm on 28 MAR 2012 at 15:30. Immediately after vaccination she experienced feeling dizzy, pale, slight diaphoretic, oriented to person and place time Her skin was clammy to touch. The nurse assisted her to sitting position. The pulse rate of 90/60, respiratory rate of 18 regular and she was answering questions when asked. The nurse monitored her for 30 min and no other incident was noted. She was originated for three days and all time monitored. After mom arrived, she was escorted to the car. The nurse followed up for the remainder of the week. The final outcome of the events was reported as completely recovered. The causality of the events was not reported.
Age: 17.0
Sex: M
Vaccine: MNQ
Symptoms: Injection site erythema, Pain in extremity
Clinical narrative: Case number PHHY2012US076835 is an initial spontaneous report received from Vaccine Adverse Event Reporting System (VAERS: 458447) website on 05 Sep 2012. This report refers to 17-year-old male patient. The patient was vaccinated with MENVEO (batch number: A11071) intramuscularly in left arm on an unspecified date. On an unspecified date, after the vaccination the patient had pain in arm (site unspecified). He also had redness at the injection site. The outcome of events was reported as complete recovery as of 27 Jun 2012 (reported date).
Age: 11.0
Sex: F
Vaccine: MNQ, TDAP
Symptoms: Injection site pain, Injection site swelling
Clinical narrative: Case number PHHY2012US076839 is an initial spontaneous report received from Vaccine Adverse Event Reporting System (VAERS: 458490) website on 05 Sep 2012. This report refers to 11-year-old female patient. The patient's medical history included dyslexia, seasonal allergies and speech disorder. Concomitant medications included loratadine and NASONEX. The patient was vaccinated with MENVEO (batch number: M10133) intramuscularly in left arm and TDAP (other manufacturer, batch number: C3941AA) intramuscularly in left arm on 16 Apr 2012. On 17 Apr 2012, one day after the vaccination, the patient experienced local swelling and tenderness at the site of injection. The outcome of events was reported as complete recovery as of 29 May 2012.
Age: 24.0
Sex: F
Vaccine: MNQ
Symptoms: Chest pain
Clinical narrative: Case number PHHY2012US076840 is an initial spontaneous report received from Vaccine Adverse Event Reporting System (VAERS: 458491) web site on 05 Sep 2012. This report refers to 24-year-old female patient. The patient was vaccinated with MENVEO (batch number: M10126A) intramuscularly in right arm on 18 Apr 2012. On 18 Apr 2012, two hours after the vaccination the patient experienced recurring chest pain that comes and goes. The outcome of events was reported as condition unchanged as of 29 Jun 2012.
Age: 17.0
Sex: F
Vaccine: HPV4, MNQ
Symptoms: Diarrhoea, Headache, Pyrexia, Vomiting
Clinical narrative: Case number PHHY2012US076844 is an initial spontaneous report received from Vaccine Adverse Event Reporting System (VAERS: 458578) web site on 05 Sep 2012. This report refers to 17-year-old female patient. The patient was vaccinated with MENVEO (batch number: U4003AA) intramuscularly in right arm and CERVARIX (other manufacturer, batch number: 0841AA) intramuscularly in right arm on 08 May 2012. On 14 May 2012, 7 days after the vaccination the patient experienced fever, headache, vomiting and diarrhea. There was no known ingestion. All the lab data were in normal range (values not reported). The outcome of events was reported as complete recovery as of 03 Jul 2012 (reported date).
Age: 11.0
Sex: F
Vaccine: HPV4, MNQ, TDAP
Symptoms: Injection site erythema, Vaccination site swelling
Clinical narrative: Case number PHHY2012US076846, is an initial spontaneous report received from vaccine adverse event reporting system (VAERS reference number: 458631) web site on 05 Sep 2012. This report refers to an 11-year-old female patient. She was vaccinated with MENVEO (batch number: X10133) in left arm, intramuscularly on 22 May 2012. She was also vaccinated with GARDASIL (batch number: 1495AA) and ADACEL (C3941AA) both intramuscularly in left arm on 22 May 2012. On the same day the patient experienced redness and swelling at the vaccination site. The outcome of the events was completely recovered. Seriousness and causality of the events was not reported.
Age: 19.0
Sex: F
Vaccine: MNQ, TDAP
Symptoms: Lip swelling
Clinical narrative: Case number PHHY2012US076847, is an initial report received from the Vaccine Adverse Event Reporting System (VAERS reference number: 458653) web site on 05 Sep 2012. This report refers to 19-years-old female patient. Her medical history was not reported. She was vaccinated with MENVEO (batch number: A11073), in the right arm and BOOSTRIX vaccine (other manufacture, batch number: AC52B078AA), in the left arm on 02 Jul 2012. On the same day after vaccination, she experienced swelling of upper lips. She was treated with BENADRYL and felt fine. The outcome of the events was reported as recovered. The causality of the events were not reported.
Age: 11.0
Sex: M
Vaccine: MNQ
Symptoms: Injection site erythema, Injection site induration, Injection site swelling, Injection site warmth, Pruritus
Clinical narrative: Case number PHHY2012US076849, is an initial report received from the Vaccine Adverse Event Reporting System (VAERS reference number: 458741) web site on 05 Sep 2012. This report refers to 11-years-old male patient. His medical history included diabetes type II, meatal stenosis and asthma. He was vaccinated with MENVEO (batch number: A11071), in the left arm intramuscularly on 25 Jun 2012. On 26 Jun 2012, he experienced area around injection site was red, swollen, hot and hard. She also complained of itching. The outcome of the events was reported as recovered. The causality of the events was not reported.
Age: 25.0
Sex: F
Vaccine: MNQ
Symptoms: Injection site bruising, Injection site erythema, Injection site pain, Injection site swelling
Clinical narrative: Case number PHHY2012US076851 is an initial spontaneous report received from Vaccine Adverse Event Reporting System (VAERS reference number: 458757) web site on 05 Sep 2012. This report refers to 25-year-old female patient. Her medical history, past drugs and current conditions were not reported. She was vaccinated with MENVEO (batch number: M11073) in the left arm on 26 Jun 2012. On 03 Jul 2012, she experienced red swollen area around where the shot was given. The area was bruised in the middle with some pain similar to what it felt like when the shot was given. The final outcome of the events was reported as completely recovered. The causality of the events was not reported.
Age: 11.0
Sex: M
Vaccine: MNQ
Symptoms: Injection site erythema, Injection site induration, Injection site swelling, Injection site warmth
Clinical narrative: Case number PHHY2012US076852 is an initial spontaneous report received from Vaccine Adverse Event Reporting System (VAERS reference number: 458782) web site on 05 Sep 2012. This report refers to 11-year-old male patient. His medical history was not reported. He was not taking any meds at this time. On 05 Jun 2012, he was received BOOSTRIX (other manufacturer, batch number: AC52B073AA) in the left arm (but it was not within the four-week prior to his MENVEO). He was vaccinated with MENVEO (batch number: M11050) in the left arm intramuscularly on 05 Jul 2012. On the same day after vaccination, he experienced swollen, red, firm and hot to touch in the left deltoid. These events got worse overnight. She was treated with BENADRYL in the office. The final outcome of the events was reported as completely recovered. The causality of the events was not reported.
Age: 12.0
Sex: M
Vaccine: MNQ
Symptoms: Injection site erythema, Injection site pain, Injection site swelling
Clinical narrative: Case number PHHY2012US076853 is an initial spontaneous report received from Vaccine Adverse Event Reporting System (VAERS reference number: 458847) web site on 05 Sep 2012. This report refers to 12-year-old male patient. His medical history, past drugs and current conditions were not reported. He was vaccinated with MENVEO (batch number: A11071) intramuscularly on the left arm on 25 Jun 2012. On the same day after vaccination, he experienced marked swelling and redness entire left arm shoulder to elbow within hours of shot some pain. The final outcome of the events was reported as condition unchanged at the time of reporting on 27 Jun 2012. The causality of the events was not reported.
Age: 15.0
Sex: M
Vaccine: MNQ
Symptoms: Chills, Hyperhidrosis, Pyrexia, Tachycardia
Clinical narrative: Case number PHHY2012YUS076854 is an initial spontaneous report received from Vaccine Adverse Event Reporting System (VAERS reference number: 458851) web site on 05 Sep 2012. This report refers to 15-year-old male patient. His medical history, past drugs and current conditions were not reported. He was vaccinated with MENVEO (batch number: A10051) intramuscularly on to the right arm on 27 Jun 2012. In the evening after vaccination, he experienced fever with 99 degree Fahrenheit , chills, sweats, tachycardia. He was treated with ADVIL for fever. These events were lasted approximately 24-hours. The final outcome of the events was reported as recovered. The causality of the events was not reported.
Age: 12.0
Sex: F
Vaccine: HPV4, MNQ, TDAP
Symptoms: Erythema, Pyrexia, Skin turgor decreased, Tenderness
Clinical narrative: Case number PHHY2012US076864 is an initial spontaneous report received from Vaccine Adverse Event Reporting System (VAERS reference number: 459222) web site on 05 Sep 2012. This report refers to 12-year-old female patient. Her medical history included allergic rhinitis and concomitant medication was not reported. She was vaccinated with MENVEO (batch number: A10065) in the left arm intramuscularly, GARDASIL (other manufacturer, batch number: 1359AA) in the left arm intramuscularly and also with BOOSTRIX (other manufacturer, batch number: AC52B072EA) in the right arm intramuscularly on 09 Jul 2012. On 11 Jul 2012, she experienced fever, turgor, erythema and tenderness. She was treated with BACTRIM 200/40/5 ml., Triamcinolone topically 0.1%, ORAPRED 15 mg/5ml and MOTRIN. The final outcome of the events was reported as recovered. The causality of the events was not reported.
Age: 45.0
Sex: F
Vaccine: MNQ
Symptoms: Pyrexia, Vaccination site swelling
Clinical narrative: Case number PHHY2012US085869 is an initial spontaneous report received from Vaccine Adverse Event Reporting System (VAERS reference number: 459287) on 02 Oct 2012. This report refers to a 45-year-old female patient. Her vaccination history included administration of a meningococcal vaccine (manufacturer and batch number: unknown), no adverse event was reported following this administration. Her concomitant medication included ATENOL 25 mg. She was vaccinated with MENVEO (batch number: X10134A) intramuscularly in to the left arm on 10 Jul 2012. On 15 Jul 2012 the site of vaccine was swollen and she felt feverish. The final outcome was reported as condition unchanged as on 15 Jul 2012. No further information about causality and seriousness was reported.
Age: 14.0
Sex: M
Vaccine: IPV, MNQ, TDAP, VARCEL
Symptoms: Abdominal discomfort, Pyrexia
Clinical narrative: Case number PHHY2012US085872, is an initial spontaneous report received from Vaccine Adverse Event Reporting System web site (reference number: 459346) on 02 Oct 2012. This report refers to 14 year old male patient. His medical history and concomitant medications were not reported. He was vaccinated with MENVEO (M10059) into right arm intramuscularly, IPOL (batch number: E0950) intramuscular into left arm and ADACEL (batch number: U3486CA), intramuscular into left arm and VARIVAX (batch number: 1061AA) subcutaneous into right arm on 11 Jul 2012. On 12 Jul 2012, the patient woke up in the morning with upset stomach and fever of 100.6 degree Fahrenheit. MOTRIN was given. Fever continued on and off through the next day and half. The final outcome of the events was recovered. Seriousness and causality of the events was not reported.
Age: 18.0
Sex: F
Vaccine: MNQ
Symptoms: Blood pressure increased, Headache, Heart rate increased, Injection site pain, Pain
Clinical narrative: Case number PHHY2012US085878, is an initial spontaneous report received from Vaccine Adverse Event Reporting System website (VAERS reference number: 459623) on 02 Oct 2012. This report refers to an 18 year old female patient. Historical condition included penicillin allergy. Concomitant medications included LOESTRIN. She was vaccinated with MENVEO (batch number: A11047), intramuscularly into the left arm on 09 Jul 2012. On the same day few hours after vaccination patient experienced arm pain at shot site, headache, and fever with body temperature 100 degree Celsius, body aches, elevated heart rate and blood pressure 170/90 by home blood pressure monitor. Patient took ADVIL and felt better. The patient came for eval but feels fine today (11 Jul 2012). Events outcome was completely recovered. Seriousness and causality assessment was not reported.
Age: 18.0
Sex: F
Vaccine: MNQ
Symptoms: Pyrexia
Clinical narrative: Case number PHHY2012US085878, is an initial spontaneous report received from Vaccine Adverse Event Reporting System website (VAERS reference number: 459623) on 02 Oct 2012. This report refers to an 18 year old female patient. Historical condition included penicillin allergy. Concomitant medications included LOESTRIN. She was vaccinated with MENVEO (batch number: A11047), intramuscularly into the left arm on 09 Jul 2012. On the same day few hours after vaccination patient experienced arm pain at shot site, headache, and fever with body temperature 100 degree Celsius, body aches, elevated heart rate and blood pressure 170/90 by home blood pressure monitor. Patient took ADVIL and felt better. The patient came for eval but feels fine today (11 Jul 2012). Events outcome was completely recovered. Seriousness and causality assessment was not reported.
Age: 11.0
Sex: M
Vaccine: HEPA, MNQ, TDAP, VARCEL
Symptoms: Injection site erythema, Injection site pruritus, Injection site swelling
Clinical narrative: Case number PHHY2012US086411 is an initial spontaneous report received from Vaccine Adverse Event Reporting System web site (VAERS reference number: 459804) on 02 Oct 2012. This case refers to an 11-year-old male patient. He was vaccinated with MENVEO (batch number: X10127B), intramuscularly into his right arm on 17 Jul 2012. On the same day he was also vaccinated with BOOSTRIX (other manufacturer, batch number: AC14B126AA) intramuscularly into his right arm, HAVRIX (other manufacturer, batch number: AHAVB515BA) intramuscularly into his left arm and VARIVAX (other manufacturer, batch number: 1942AA) subcutaneously in left arm. On 18 Jul 2012, he presented with red slightly raised area (6-7 cm) in diameter on right upper arm. He also complained of itching at that site. His mother stated that the symptoms started a day after vaccination and was getting bigger. The patient was treated with BENADRYL 35 mg thrice daily and prednisone 20 mg twice daily for five days as per a doctor's advice. The final outcome was reported as completely recovered as of 20 Jul 2012. No other information was available.
Age: 12.0
Sex: F
Vaccine: HPV4, MNQ
Symptoms: Rash generalised, Urticaria
Clinical narrative: Case number PHHY2012US085901 is an initial spontaneous report received from Vaccine Adverse Event Reporting System web site (VAERS reference number: 461362) on 02 Oct 2012. This case refers to a 12-year-old female patient. She was vaccinated with MENVEO (batch number: M10134A) intramuscularly on 16 Jul 2012. On the same day she was also vaccinated intramuscularly with GARDASIL (other manufacturer, and batch number: 1291AA). Two days after vaccination she developed rash on body. Her mom stated that urticarial rash appeared primarily on torso. The final outcome was reported as completely recovered as of 18 Jul 2012. No other information was available.
Age: 22.0
Sex: F
Vaccine: MNQ
Symptoms: Expired product administered, No adverse event
Clinical narrative: Case number PHHY2012US085849 is an initial spontaneous report received from vaccine adverse event reporting system (VAERS reference number: : 460154) web site on 02 Oct 2012. This report refers to a 22-year-old female patient. Her medical history and concomitant medications were not reported. She was vaccinated with expired MENVEO (batch number: M10027, expiry date: not reported) intramuscularly on to left arm on 16 Jul 2012. It was reported that the vaccine was expired by two and a half months. The patient was re-immunized as advised by the medical director to make sure that valid dose was administered. No adverse reaction was reported following the inadvertent administration.
Age: 11.0
Sex: M
Vaccine: HPV4, MNQ, TDAP
Symptoms: Condition aggravated, Dyspnoea, Eczema, Injected limb mobility decreased, Injection site discolouration
Clinical narrative: Case number PHHY2012US085854 is an initial spontaneous report received from Vaccine Adverse Event Reporting System (VAERS reference number: 460264) on 02 Oct 2012: This report refers to an 11-year-old male patient. His pre-existing condition included severe asthma and eczema. His concomitant medications included ZANTAC 150 mg/day, ZYRTEC twice daily, albuterol inhaler and SINGULAIR 10 mg/day (two puffs). He was vaccinated with MENVEO (batch number: M10132) intramuscularly in to the right arm along with BOOSTRIX (other manufacturer, batch number: AC52B085) intramuscularly in to the left arm and GARDASIL (other manufacturer, batch number: 1495AA) intramuscularly in to the left arm on 19 Jul 2012. On 20 Jul 2012 his arm hurt, the area from injection site to elbow was swollen, purple, red, itchy, hot and painful and the arm was difficult to move. His eczema "ached up" in right arm elbow and physician was called. He was given BENADRYL 25 mg and ice was applied to the area. He needed nebulizer treatment at home because of respiratory difficulties. On 23 Jul 2012 the reaction was resolving however it still looked red in color and was painful and itchy. The final outcome was reported as condition unchanged as on 23 Jul 2012. No further information about causality and seriousness was reported.
Age: 11.0
Sex: M
Vaccine: HPV4, MNQ, TDAP
Symptoms: Injection site erythema, Injection site pain, Injection site pruritus, Injection site swelling, Injection site warmth
Clinical narrative: Case number PHHY2012US085854 is an initial spontaneous report received from Vaccine Adverse Event Reporting System (VAERS reference number: 460264) on 02 Oct 2012: This report refers to an 11-year-old male patient. His pre-existing condition included severe asthma and eczema. His concomitant medications included ZANTAC 150 mg/day, ZYRTEC twice daily, albuterol inhaler and SINGULAIR 10 mg/day (two puffs). He was vaccinated with MENVEO (batch number: M10132) intramuscularly in to the right arm along with BOOSTRIX (other manufacturer, batch number: AC52B085) intramuscularly in to the left arm and GARDASIL (other manufacturer, batch number: 1495AA) intramuscularly in to the left arm on 19 Jul 2012. On 20 Jul 2012 his arm hurt, the area from injection site to elbow was swollen, purple, red, itchy, hot and painful and the arm was difficult to move. His eczema "ached up" in right arm elbow and physician was called. He was given BENADRYL 25 mg and ice was applied to the area. He needed nebulizer treatment at home because of respiratory difficulties. On 23 Jul 2012 the reaction was resolving however it still looked red in color and was painful and itchy. The final outcome was reported as condition unchanged as on 23 Jul 2012. No further information about causality and seriousness was reported.
Age: 11.0
Sex: M
Vaccine: HPV4, MNQ, TDAP
Symptoms: Pain in extremity
Clinical narrative: Case number PHHY2012US085854 is an initial spontaneous report received from Vaccine Adverse Event Reporting System (VAERS reference number: 460264) on 02 Oct 2012: This report refers to an 11-year-old male patient. His pre-existing condition included severe asthma and eczema. His concomitant medications included ZANTAC 150 mg/day, ZYRTEC twice daily, albuterol inhaler and SINGULAIR 10 mg/day (two puffs). He was vaccinated with MENVEO (batch number: M10132) intramuscularly in to the right arm along with BOOSTRIX (other manufacturer, batch number: AC52B085) intramuscularly in to the left arm and GARDASIL (other manufacturer, batch number: 1495AA) intramuscularly in to the left arm on 19 Jul 2012. On 20 Jul 2012 his arm hurt, the area from injection site to elbow was swollen, purple, red, itchy, hot and painful and the arm was difficult to move. His eczema "ached up" in right arm elbow and physician was called. He was given BENADRYL 25 mg and ice was applied to the area. He needed nebulizer treatment at home because of respiratory difficulties. On 23 Jul 2012 the reaction was resolving however it still looked red in color and was painful and itchy. The final outcome was reported as condition unchanged as on 23 Jul 2012. No further information about causality and seriousness was reported.
Age: 11.0
Sex: M
Vaccine: MNQ, TDAP
Symptoms: Injection site erythema, Injection site pruritus, Injection site swelling
Clinical narrative: Case number PHHY2012US085858 is an initial spontaneous report received from Vaccine Adverse Event Reporting System (VAERS reference number: 460314) on 02 Oct 2012: This report refers to an 11-year-old male patient. His medical history included Asperger's disorder. He was vaccinated with MENVEO (batch number: A11041) intramuscularly in to the right arm along with BOOSTRIX (other manufacturer, batch number: AC52B085BA) intramuscularly in to the left arm on 14 Jul 2012. On 15 Jul 2012 he began itching at the right arm where MENVEO was administered. Shortly after, swelling and redness developed. He was seen in the Emergency Room (ER) where they advised to take ibuprofen, ice and BENADRYL. The reporter spoke to patient's mother on 16 Jul 2012 and reinforced ER advice. The final outcome was reported as complete recovery on an unspecified date. No further information about causality and seriousness was reported.
Age: 11.0
Sex: M
Vaccine: MNQ, TDAP
Symptoms: Injection site erythema, Injection site swelling
Clinical narrative: Case number PHHY2012US0085864 is an initial spontaneous report received from Vaccine Adverse Event Reporting System (VAERS reference number: 460471) on 02 Oct 2012: This report refers to an 11-year-old male patient. He was vaccinated with MENVEO (batch number: A111041) intramuscularly in to the left arm along with BOOSTRIX (other manufacturer, batch number: AC52B072AA) intramuscularly in to the right arm on 24 Jul 2012. On 25 Jul 2012 he experienced swelling and redness of 6 x 6 inches at the left deltoid. He did not have any breathing difficulties. The final outcome was reported as complete recovery on an unspecified date. No further information about causality and seriousness was reported.
Age: 11.0
Sex: M
Vaccine: MNQ, TDAP
Symptoms: Erythema, Local swelling, Skin warm
Clinical narrative: Case number PHHY2012US085868 is an initial spontaneous report received from Vaccine Adverse Event Reporting System (VAERS reference number; 460475) on 02 Oct 2012: This report refers to an 11-year-old male patient. He was vaccinated with MENVEO (batch number: A11041) in to the right arm along with BOOSTRIX (other manufacturer, batch number: AC52B085CA)) in to the right arm on 23 Jul 2012. On the same day after vaccination he developed 3.5 x 4 inches redness and swelling which was warm to touch in the right arm. He did not have any breathing difficulties. The final outcome was reported as complete recovery on an unspecified date. No further information about causality and seriousness was reported.
Age: 11.0
Sex: M
Vaccine: MNQ, TDAP
Symptoms: Rash
Clinical narrative: Case number PHHY2012US088645 is an initial spontaneous report received from vaccine adverse event reporting system website (VAERS reference number: 460510) on 02 Oct 2012. This case refers to a 11-year old male patient. He was vaccinated with MENVEO (batch number: A11071) into his right arm on 20 Jul 2012. On the same day he was also vaccinated with ADACEL (other manufacturer, batch number: C4247AA) into his left arm. On the same day he developed rash in left axilla and lower back. There was questionable hives in the same area. He had an emergency doctor visit due to these events. He had no respiratory, no gastrointestinal and no neurological symptoms. He responded well to steroid and antihistamines. The final outcome was reported as completely recovered as of 23 Jul 2012. No other information was available.
Age: 13.0
Sex: M
Vaccine: HEPA, MNQ, TDAP
Symptoms: Erythema, Hypersensitivity, Pruritus, Swelling
Clinical narrative: Case number PHHY2012US085871, is an initial spontaneous report received from Vaccine Adverse Event Reporting System web site (reference number: 460630) on 02 Oct 2012. This report refers to 13 year old male patient. Current condition included diabetes. Concomitant medications included insulin. He was vaccinated with MENVEO (batch number: M11052) intramuscular, into the left arm; ADACEL (batch number: C4149AA) intramuscular into the left arm and VAQTA (batch number: 0325AE) intramuscular into the right arm, all on 25 Jul 2012. The patients father reported that on 26 Jul 2012, the patient had an allergic reaction described as redness, swelling and itchy approximately 15 to 20 cm of redness. He had applied cold compress and event was improving. No wheezing or difficulty breathing. The final outcome of the events was recovered. Seriousness and causality of the events was not reported.
Age: 11.0
Sex: M
Vaccine: HPV4, MNQ, TDAP
Symptoms: Injection site erythema, Injection site pain, Injection site swelling, Pain
Clinical narrative: Case number PHHY2012US085894 is an initial spontaneous report received from Vaccine Adverse Event Reporting System (VAERS reference number: 460913) website on 02 Oct 2012. This report refers to a 11-year-old male patient. His medical history and current conditions were not reported. He was vaccinated with MENVEO (batch number: A11042) and BOOSTRIX (other manufacturer and batch number: AC52B085AA) intramuscularly on to left arm and GARDASIL (other manufacturer, batch number: 0754AE) intramuscularly on to right arm on 01 Aug 2012. After vaccination on 02 Aug 2012 he experienced redness, swelling and tenderness in the left upper arm. The redness and swelling radiated approximately 1 inch above elbow. It was reported that he complained of pain only when arm was bent. He was with his mother at his side and she wanted to patient be evaluated. Following these events he went to the emergency room. The final outcome of the events was reported as condition unchanged at the time of reporting on 02 Aug 2012. No additional information about the causality of the events was available.
Age: 11.0
Sex: M
Vaccine: HPV4, MNQ, TDAP
Symptoms: Injection site erythema, Injection site swelling
Clinical narrative: Case number PHHY2012US085905 is an initial spontaneous report received from a vaccine adverse event reporting system website (VAERS reference number: 461058) on 02 Oct 2012. This case refers to a 11-year-old male patient. He was vaccinated with MENVEO (batch number: M11066) intramuscularly into his left arm on 31 Jul 2012. On the same day he was also vaccinated with BOOSTRIX (batch number: ACB074CA) intramuscularly into his left arm and GARDASIL (batch number: 1495AA) intramuscularly into his right arm. One day after vaccination he developed swelling and redness in the left arm from deltoid to elbow where MENVEO and BOOSTRIX where administered. The final outcome was reported as condition unchanged as of 03 Aug 2012. No other information was available.
Age: 52.0
Sex: M
Vaccine: IPV, MNQ, PPV, TYP, YF
Symptoms: Muscle twitching
Clinical narrative: Case number PHHY2012US085732 is an initial spontaneous report received from vaccine adverse event reporting system website (VAERS reference number: 461123) on 02 Oct 2012. This case refers to a 52-year-old male patient. His preexisting condition included of asthma. His concomitant medications included of SYMBICORT. He was vaccinated with MENVEO (batch number: M11071) intramuscularly into his left arm on 10 Jul 2012. On the same day he was also vaccinated with IPOL (other manufacturer, batch number: H1305) subcutaneously in his right arm, PNEUMOVAX (other manufacturer, batch number: 0595AA) intramuscularly in his left arm, TYPHIM VI  (other manufacturer, batch number: G1130) intramuscularly in his right arm and YF-VAX (other manufacturer, batch number: UH287AA) subcutaneously in his right arm. On 23 Jul 2012, the patient reported of left arm twitching near the injection site. There was no pain, no swelling and no redness. The final outcome was reported as completely recovered. No other information was available.
Age: 18.0
Sex: F
Vaccine: MNQ
Symptoms: Asthenia, Gait disturbance, Injection site erythema, Injection site swelling, Injection site warmth
Clinical narrative: Case number PHHY2012US085733 is an initial spontaneous report received from vaccine adverse event reporting system (VAERS reference number: 461124) web site on 02 Oct 2012. This report refers to 18-year-old female patient. Her medical history included allergy to erythromycin, CECLOR, ZITHROMAX and egg. Her pre-existing conditions included of influenza, asthma, and excessive menstruation. Her concomitant medications included of cetirizine, EPIPEN and glucose oral gel. She was vaccinated with MENVEO (batch number: M10134A) into right arm on 01 Aug 2012. On the same day after vaccination she experienced red, swollen right upper arm which was warm to touch. She also experienced generalized weakness, muscle pain and unsteady gait. Following these events she made a visit to the emergency room. The final outcome of the events was reported as condition unchanged as of 06 Aug 2012. No additional information about the causality of the events was available.
Age: 18.0
Sex: F
Vaccine: MNQ
Symptoms: Myalgia
Clinical narrative: Case number PHHY2012US085733 is an initial spontaneous report received from vaccine adverse event reporting system (VAERS reference number: 461124) web site on 02 Oct 2012. This report refers to 18-year-old female patient. Her medical history included allergy to erythromycin, CECLOR, ZITHROMAX and egg. Her pre-existing conditions included of influenza, asthma, and excessive menstruation. Her concomitant medications included of cetirizine, EPIPEN and glucose oral gel. She was vaccinated with MENVEO (batch number: M10134A) into right arm on 01 Aug 2012. On the same day after vaccination she experienced red, swollen right upper arm which was warm to touch. She also experienced generalized weakness, muscle pain and unsteady gait. Following these events she made a visit to the emergency room. The final outcome of the events was reported as condition unchanged as of 06 Aug 2012. No additional information about the causality of the events was available.
Age: 18.0
Sex: F
Vaccine: MNQ
Symptoms: Headache, Rash pruritic
Clinical narrative: Case number PHHY2012US085734 is an initial spontaneous report received from Vaccine Adverse Event Reporting System (VAERS reference number: 461270) website on 02 Oct 2012. This report refers to a 18-year-old female patient. Her current conditions included acne and dysmenorrhea. Her concomitant medications included TRI-SPRINTEC and NAPROSYN. She was vaccinated with MENVEO (batch number: M1105) intramuscularly in left arm on 06 Aug 2012. On the same day three hours after vaccination she experienced headache and woke up with a headache the next day as well. She also experienced itchy facial rash on 07 Aug 2012. The final outcome of the events was reported as completely recovered as of 07 Aug 2012. No additional information about the causality of the events was available.
Age: 11.0
Sex: F
Vaccine: HPV4, MNQ, TDAP
Symptoms: Diarrhoea, Palpitations, Pyrexia, Streptococcus test negative, Vomiting
Clinical narrative: Case number PHHY2012US085744 is an initial spontaneous report received from vaccine adverse event reporting system website (VAERS reference number: 461314) on 02 Oct 2012. This case refers to a 11-year-old female patient. Her concomitant medications included erythromycin ointment. Concurrent illness included conjunctivitis. She was vaccinated with MENVEO (batch number: M11042) intramuscularly into her right arm on 30 Jul 2012. On the same day she was also vaccinated with GARDASIL (batch number: 0022AE) intramuscularly into her right arm and BOOSTRIX (batch number: AC52B081AA) intramuscularly into her left arm. On 30 Jul 2012, after vaccination she experienced fever, vomiting, diarrhea and heart racing. The rapid Streptococcus test was negative. She had an emergency doctor visit due to these events. The final outcome was reported as condition unchanged as of 01 Aug 2012. No other information was available.